Striatal Response to Reward Anticipation as a Biomarker for Schizophrenia and Negative Symptoms: Effects, Test-Retest Reliability, and Stability Across Sites.

Autor:	Carruzzo F; Department of Psychiatry, Clinical and Experimental Psychopathology Laboratory, University Hospital Geneva, Thônex, Switzerland., Kaliuzhna M; Department of Psychiatry, Clinical and Experimental Psychopathology Laboratory, University Hospital Geneva, Thônex, Switzerland., Kuenzi N; Department of Psychiatry, Clinical and Experimental Psychopathology Laboratory, University Hospital Geneva, Thônex, Switzerland., Geffen T; Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, Berlin, Germany., Katthagen T; Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, Berlin, Germany., Schlagenhauf F; Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, Berlin, Germany., Kaiser S; Department of Psychiatry, Clinical and Experimental Psychopathology Laboratory, University Hospital Geneva, Thônex, Switzerland.
Jazyk:	angličtina
Zdroj:	Schizophrenia bulletin [Schizophr Bull] 2024 Jul 27; Vol. 50 (4), pp. 733-746.
DOI:	10.1093/schbul/sbae046
Abstrakt:	Background: Ventral striatal hypoactivation during reward anticipation has consistently been observed in patients with schizophrenia. In addition, that hypoactivation has been shown to correlate negatively with negative symptoms, and in particular with apathy. However, little is known about the stability of these results over time and their reliability across different centers. Methods: In total, 67 patients with schizophrenia (15 females) and 55 healthy controls (13 females) were recruited in 2 centers in Switzerland and Germany. To assess the neural bases of reward anticipation, all participants performed a variant of the Monetary Incentive Delay task while undergoing event-related functional magnetic resonance imaging at baseline and after 3 months. Stability over time was measured using intra-class correlation (ICC(A,1)) and stability between centers was measured with mixed models. Results: Results showed the expected ventral striatal hypoactivation in patients compared to controls during reward anticipation. We showed that these results were stable across centers. The primary analysis did not reveal an effect of time. Test-retest reliability was moderate for controls, and poor for patients. We did not find an association between ventral striatal hypoactivation and negative symptoms in patients. Conclusions: Our results align with the hypothesis that ventral striatal activation is related to modulation of motivational saliency during reward anticipation. They also confirm that patients with schizophrenia show impaired reward anticipation. However, the poor test-retest reliability and the absence of an association with symptoms suggests that further research is needed before ventral striatal activity can be used as a biomarker on the individual patient level. (© The Author(s) 2024. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu